NeoPharm (Korea) Today
| 092730 Stock | KRW 12,000 90.00 0.74% |
Performance4 of 100
| Odds Of DistressLess than 9
|
NeoPharm is trading at 12000.00 as of the 17th of December 2024, a 0.74 percent decrease since the beginning of the trading day. The stock's open price was 12090.0. NeoPharm has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. NeoPharm has reported 1 for 2 split on 30th of October 2024. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 7.99 M outstanding shares. More on NeoPharm LTD
NeoPharm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NeoPharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NeoPharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Consumer Staples, Personal Products (View all Sectors) |
NeoPharm LTD (092730) is traded on KOSDAQ in Korea and employs 106 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 156.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeoPharm's market, we take the total number of its shares issued and multiply it by NeoPharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NeoPharm LTD has 7.99 M outstanding shares.
NeoPharm LTD has accumulated about 7.05 B in cash with 21.68 B of positive cash flow from operations.
Check NeoPharm Probability Of Bankruptcy
Ownership AllocationThe market capitalization of NeoPharm LTD is W156.02 Billion. NeoPharm LTD holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check NeoPharm Ownership Details
NeoPharm LTD Risk Profiles
Although NeoPharm's alpha and beta are two of the key measurements used to evaluate NeoPharm's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.23 | |||
| Semi Deviation | 2.48 | |||
| Standard Deviation | 2.93 | |||
| Variance | 8.59 |
NeoPharm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in NeoPharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Other Information on Investing in NeoPharm Stock
NeoPharm financial ratios help investors to determine whether NeoPharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NeoPharm with respect to the benefits of owning NeoPharm security.